Legend Biotech's January 2025 6-K Report: Corporate Updates & Presentation Insights

Here are the key insights extracted from the provided section of the financial report:

1. Company Information:

• Name: Legend Biotech Corporation
• Address: 2101 Cottontail Lane, Somerset, New Jersey 08873

2. Filing Details:

• Form Type: 6-K (Report of Foreign Private Issuer)
• Date of Report: January 14, 2025
• Commission File Number: 001-39307

3. Corporate Presentation:

• Legend Biotech will make an updated corporate presentation available on its website.
• The presentation is attached as Exhibit 99.1 and can be viewed at the company’s investor relations website: Legend Biotech Investor Events.

4. Incorporation of Information:

• The report, including Exhibit 99.1 (except for the section under "About Legend Biotech"), is incorporated by reference in the company's registration statements on Form F-3 and Form S-8.

5. Exhibit Index:

• Exhibit 99.1: Corporate Presentation - January 2025

6. Signature:

• The report is signed by Ying Huang, Ph.D., who is the Chief Executive Officer of the company.

7. Regulatory Compliance:

• The filing is made in compliance with the requirements of the Securities Exchange Act of 1934.

This information outlines the key elements of the filing, including corporate updates, compliance, and the leadership responsible for the report.